... A web-based Atlas of Patient-Derived Xenografts of cancer patients:A resource of MURAL PDX data
Home
Search by IDs Search by Gene
Browse
With gene expression Without gene expression Mutation & CNV Plot
Patient Tumor & Clinical details PDX & PDXBiomarker details
View & Update
Statistics



PDX model details

PDX ID 330M
Host Strain(and Source) NSG
Source: Monash University
Host Strain Immune system Humanized NO
Host Type Testosterone supplemented
Graft Site Subcutaneous
Current Generation
(* indicates number of generations grown in Castrate host)
 18
Average PDX Generation Time (days +/- SEM) 90 ± 9
Tumor preparation Tumor solid
Tumor Characterization Technology Histology, IHC, STR profiling, targeted DNA sequencing, RNAseq
Tumor confirmed not to be of Mouse/EBV origin Yes; negative for CD45 and/or positive for human CK8/18 and/or human mitochondria by IHC
Passage QA performed Routine QA every 2-3 passages
Associated meta data
PDX model availability Yes (fixed, frozen)
Governance restriction for distribution Available to investigators with appropriate ethics approvals, approved EOI from MURAL committee, and material transfer agreements
Pubmed ID 34413304
Markers 330M
AR Y
PSA Y
PSMA Y
NE N
ERG N
This heatmap displays the call type of curated CNVs in the presented samples.
This heatmap displays the call type of CNVs in commonly occurred samples.

PDX ID Gene Symbol CNV Log2 CNV Copy CNV Call Experiments name Platform Reference genome
330M AR 4.35528 20.4677 gain-high MURAL Prostate Cancer PDX collection Targeted Twist Panel hg19
330M BRAF 0.734635 3.32795 gain MURAL Prostate Cancer PDX collection Targeted Twist Panel hg19
330M CDH1 -0.794911 1.15276 loss MURAL Prostate Cancer PDX collection Targeted Twist Panel hg19
330M CDKN1B -1.51138 0.701551 loss MURAL Prostate Cancer PDX collection Targeted Twist Panel hg19
330M EZH2 0.884104 3.69124 gain MURAL Prostate Cancer PDX collection Targeted Twist Panel hg19
330M EZH2 0.773784 3.4195 gain MURAL Prostate Cancer PDX collection Targeted Twist Panel hg19
330M KEAP1 -0.975087 1.01742 loss MURAL Prostate Cancer PDX collection Targeted Twist Panel hg19
330M KEAP1 -0.740461 1.1971 loss MURAL Prostate Cancer PDX collection Targeted Twist Panel hg19
330M KMT2C -1.3946 0.7607 loss MURAL Prostate Cancer PDX collection Targeted Twist Panel hg19
330M MET 0.840345 3.58096 gain MURAL Prostate Cancer PDX collection Targeted Twist Panel hg19
330M PALB2 -0.806289 1.1437 loss MURAL Prostate Cancer PDX collection Targeted Twist Panel hg19
330M PIK3CA 0.833574 3.56419 gain MURAL Prostate Cancer PDX collection Targeted Twist Panel hg19
330M PIK3CB 0.797774 3.47683 gain MURAL Prostate Cancer PDX collection Targeted Twist Panel hg19
330M PIK3CB 0.608296 3.04892 gain MURAL Prostate Cancer PDX collection Targeted Twist Panel hg19
330M PIK3R2 0.723459 3.30227 gain MURAL Prostate Cancer PDX collection Targeted Twist Panel hg19
330M SETDB1 1.79844 6.95688 gain MURAL Prostate Cancer PDX collection Targeted Twist Panel hg19
330M TP53 -0.802157 1.14698 loss MURAL Prostate Cancer PDX collection Targeted Twist Panel hg19

Clinical Information

Sample Number 330M
Sample Site Liver
Sample source Biopsy
Pathology Tumor Diagnosis Adenocarcinoma
Gleason Score None
Primary Gleason Score None
Secondary Gleason Score None
Tertiary Gleason Score None
ISUP Grade Group
Tumor Grade
D'Amico Risk Classification
Tumor Volume (in cc) 0.0
Treatment Prior to Specimen Collection ADT, docetaxel, cabazitaxel, abiraterone, enzalutamide

Patient Information

Patient Number 330
Sex Male
Diagnosis Prostate Cancer
PSA at diagnosis (ng/mL) NA
Consent to share data

Patient Tumor Collection (Current Model)
Tumour sample ID 330M
Patient Age (binned in 5 year age groups) 55-59
This heatmap displays the mutations of curated sequence variants.
Download The Mut plot is not shown
PDX ID Gene Symbol Depth ALT_FREQ Consequence Exon GnomAD_AF CADD_PHRED Clinvar_clnsig Platform Experiments Name Reference Library Type Instrument Type
330M TP53 200 0.99 splice_acceptor_variant . . 24.8 - Targeted Twist Panel MURAL Prostate Cancer PDX collection hg19 paired NextSeq 500
330M RB1 197 0.99 stop_gained '20/27 . 43 - Targeted Twist Panel MURAL Prostate Cancer PDX collection hg19 paired NextSeq 500
330M MAG 377 0.66 missense_variant '4/11 4.08E-06 25.2 - Targeted Twist Panel MURAL Prostate Cancer PDX collection hg19 paired NextSeq 500
330M VPS13B 316 0.6 stop_gained '20/62 . 39 Pathogenic/Likely_pathogenic Targeted Twist Panel MURAL Prostate Cancer PDX collection hg19 paired NextSeq 500
330M RET 499 0.47 missense_variant '11/20 . 22.9 - Targeted Twist Panel MURAL Prostate Cancer PDX collection hg19 paired NextSeq 500
330M MEN1 230 0.4 missense_variant '2/10 . 22.4 - Targeted Twist Panel MURAL Prostate Cancer PDX collection hg19 paired NextSeq 500
330M LTBP4 601 0.32 missense_variant '34/34 0.0003721 27.5 - Targeted Twist Panel MURAL Prostate Cancer PDX collection hg19 paired NextSeq 500
330M MAST4 252 0.29 splice_donor_variant . . 34 - Targeted Twist Panel MURAL Prostate Cancer PDX collection hg19 paired NextSeq 500
330M XIRP2 428 0.29 missense_variant '9/11 . 25.6 - Targeted Twist Panel MURAL Prostate Cancer PDX collection hg19 paired NextSeq 500